BiotechTube

Norgestimate/Ehinyl Estradiol; Folic acid.

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Female Contraception

Conditions

Female Contraception, Contraception, Therapeutic Equivalency, Pharmacokinetics

Trial Timeline

May 1, 2005 โ†’ Aug 1, 2005

NCT ID
NCT00709189

About Norgestimate/Ehinyl Estradiol; Folic acid.

Norgestimate/Ehinyl Estradiol; Folic acid. is a phase 1 stage product being developed by Johnson & Johnson for Female Contraception. The current trial status is completed. This product is registered under clinical trial identifier NCT00709189. Target conditions include Female Contraception, Contraception, Therapeutic Equivalency.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00709189Phase 1Completed

Competing Products

20 competing products in Female Contraception

See all competitors
ProductCompanyStageHype Score
Fulvestrant + AbemaciclibEli LillyPhase 2
52
Gemcitabine + liposomal doxorubicinEli LillyPhase 3
77
ASP3325 + PlaceboAstellas PharmaPhase 1
33
EnsitrelvirShionogiPhase 1
33
Eribulin Injection [Halaven] + Paclitaxel injectionEisaiApproved
85
Gemcitabine + Paclitaxel + CarboplatinEli LillyPhase 3
77
Abemaciclib 50 MG; 150mg 1-0-1 per osEli LillyPhase 3
77
Abemaciclib, durvalumab and aromatase inhibitorEli LillyPhase 1
33
norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.Johnson & JohnsonPhase 1
33
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR7280 tabletsJiangsu Hengrui MedicinePhase 2
52
SHR7280๏ผ›Ganirelix Acetate Injection simulant + SHR7280 simulant๏ผ› Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
77
SHR3162Jiangsu Hengrui MedicinePhase 1
33
AZD3293 + PlaceboAstraZenecaPhase 1
33
Fulvestrant 500mg + Palbociclib 125mg + Goserelin 3.6 MG + PlacebosAstraZenecaPhase 3
77
AZD2516 + PlaceboAstraZenecaPhase 1
33
Durvalumab + TremelimumabAstraZenecaPhase 2
52
Dapagliflozin + Metformin + Dapagliflozin + MetforminAstraZenecaPhase 1
33
AZD4901 (oral) + Placebo to match AZD4901AstraZenecaPhase 2
52
Zibotentan + EE/LNGAstraZenecaPhase 1
33

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85